Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dimoveo Medical is an Israeli medtech company developing a drug-free irrigation and debridement system for cleaning infected internal body cavities around implants without removing the implant. Its core technology uses ultrasound-accelerated nanoparticles to disrupt and remove biofilm in hard-to-reach surgical spaces, with an initial focus on orthopedic implant infections such as infected knee joints after arthroplasty. The company positions its system as an adjunct or improvement to standard irrigation and debridement procedures, with the goal of reducing the need for full revision surgery. Dimoveo appears to be a private, early-stage company that emerged from the MEDX Xelerator ecosystem and remains focused on hospital-based surgical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dimoveo Medical.